ALS/FTD |
ATXN2 |
Amyotrophic lateral sclerosis 13 |
ALS13 |
183,090 |
C9orf72 |
Frontotemporal dementia and/or amyotrophic lateral sclerosis 1 |
FTDALS1 |
105,550 |
DCTN1 |
Amyotrophic lateral sclerosis |
ALS |
105,400 |
FIG4 |
Amyotrophic lateral sclerosis 11 |
ALS11 |
612,577 |
FUS |
Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia |
ALS6 |
608,030 |
MATR3 |
Amyotrophic lateral sclerosis 21 |
ALS21 |
606,070 |
SQSTM1 |
Frontotemporal dementia and/or amyotrophic lateral sclerosis 3 |
FTDALS3 |
616,437 |
TARDBP |
Amyotrophic lateral sclerosis 10 |
ALS10 |
612,069 |
OTHER NEURODEGENERATION DISEASES |
AIFM1 |
Combined oxidative phosphorylation deficiency 6 |
COXPD6 |
300,816 |
ATXN2 |
Spinocerebellar ataxia 2 |
SCA2 |
183,090 |
CTSD |
Ceroid lipofuscinosis, neuronal, 10 |
CLN10 |
610,127 |
DYNC1H1 |
Spinal muscular atrophy, lower extremity-predominant 1, autosomal dominant |
SMALED1 |
158,600 |
EIF4G1 |
Parkinson disease 18 |
PARK18 |
614,251 |
NOP56 |
Spinocerebellar ataxia 36 |
SCA36 |
614,153 |
PARK7 |
Parkinson disease 7 |
PARK7 |
606,324 |
PCNA |
Ataxia-telangiectasia-like disorder 2 |
ATLD2 |
615,919 |
PUM1 |
Spinocerebellar ataxia 47 |
SCA47 |
617,931 |
QARS |
Microcephaly, progressive, with seizures and cerebral and cerebellar atrophy |
MSCCA |
615,760 |
RARS |
Leukodystrophy, hypomyelinating, 9 |
HLD9 |
616,140 |
SPG20 |
Spastic paraplegia 20, autosomal recessive |
SPG20 |
275,900 |
STUB1 |
Spinocerebellar ataxia, autosomal recessive, 16 |
SCAR16 |
615,768 |
WNK1 |
Neuropathy, hereditary sensory and autonomic, 2A |
HSAN2A |
201,300 |
OTHER NEUROLOGICAL CONDITIONS |
ADAR |
Aicardi-Goutieres syndrome 6 |
AGS6 |
615,010 |
ADNP |
Helsmoortel-van der Aa syndrome |
HVDAS |
615,873 |
AIFM1 |
Cowchock syndrome |
COWCK |
310,490 |
AIMP1 |
Leukodystrophy, hypomyelinating, 3 |
HLD3 |
260,600 |
AIMP2 |
Leukodystrophy, hypomyelinating, 17 |
HLD17 |
618,006 |
ALDH18A1 |
Spastic paraplegia 9A, autosomal dominant |
SPG9A |
601,162 |
ALDH18A1 |
Spastic paraplegia 9B, autosomal recessive |
SPG9B |
616,586 |
ALDH3A2 |
Sjogren-Larsson syndrome |
SLS |
270,200 |
ARHGEF2 |
Neurodevelopmental disorder with midbrain and hindbrain malformations |
NEDMHM |
617,523 |
ATAD3A |
Harel-Yoon syndrome |
ATAD3A |
612,316 |
ATP1A1 |
Charcot-Marie-Tooth disease, axonal, type 2DD |
CMT2DD |
618,036 |
CAD |
Epileptic encephalopathy, early infantile, 50 |
AR |
616,457 |
CDK5 |
Lissencephaly 7, with cerebellar hypoplasia |
LIS7 |
616,342 |
CLTC |
Mental retardation, autosomal dominant 56 |
MRD56 |
617,854 |
COPB2 |
Microcephaly 19, primary, autosomal recessive |
MCPH19 |
617,800 |
DARS |
Hypomyelination with brainstem and spinal cord involvement and leg spasticity |
HBSL |
615,281 |
DCTN1 |
Neuronopathy, distal hereditary motor, 7B |
HMN7B |
607,641 |
DCTN1 |
Perry syndrome |
PERRYS |
168,605 |
DOCK7 |
Epileptic encephalopathy, early infantile, 23 |
AR |
615,859 |
DYNC1H1 |
Charcot-Marie-Tooth disease 2O |
CMT2O |
614,228 |
DYNC1H1 |
Mental retardation, autosomal dominant 13 |
MRD13 |
614,563 |
EPRS |
Leukodystrophy, hypomyelinating, 15 |
HLD15 |
617,951 |
FIG4 |
Polymicrogyria, bilateral temporooccipital |
BTOP |
612,691 |
FIG4 |
Charcot-Marie-Tooth disease 4 J |
CMT4J |
611,228 |
FKBP5 |
{Major depressive disorder and accelerated response to antidepressant drugs} |
MDD |
608,516 |
FMR1 |
Fragile X syndrome |
FRAX |
300,624 |
FMR1 |
Fragile X tremor/ataxia syndrome |
FXTAS |
300,623 |
GATAD2B |
Mental retardation, autosomal dominant 18 |
MRD18 |
615,074 |
HCFC1 |
Mental retardation, X-linked 3 |
MRX3 |
309,541 |
HNRNPH2 |
Mental retardation, X-linked, syndromic, Bain type |
MRXSB |
300,986 |
HPRT1 |
Lesch-Nyhan syndrome |
LNS |
300,322 |
HSD17B4 |
Perrault syndrome 1 |
PRLTS1 |
233,400 |
HSPB1 |
Neuropathy, distal hereditary motor, type IIB |
HMN2B |
608,634 |
HSPB1 |
Charcot-Marie-Tooth disease 2F |
CMT2F |
606,595 |
HUWE1 |
Mental retardation, X-linked 17 |
MRX17 |
300,705 |
HUWE1 |
Mental retardation, X-linked, syndromic, Turner type |
MRXST |
300,706 |
LAS1L |
Wilson-Turner syndrome |
WTS |
309,585 |
LMNA |
Charcot-Marie-Tooth disease 2B1 |
CMT2B1 |
605,588 |
LRPPRC |
Leigh syndrome French-Canadian type |
LSFC |
220,111 |
MARS |
Charcot-Marie-Tooth disease 2 U |
CMT2U |
616,280 |
MTHFD1 |
Neural tube defects, folate-sensitive |
NTDFS |
601,634 |
NSUN2 |
Mental retardation, autosomal recessive 5 |
MRT5 |
611,091 |
PDK3 |
Charcot-Marie-Tooth disease, X-linked dominant, 6 |
CMTX6 |
300,905 |
PPP2R1A |
Mental retardation, autosomal dominant 36 |
MRD36 |
616,362 |
PSMD12 |
Stankiewicz-Isidor syndrome |
STISS |
617,516 |
RANBP2 |
Encephalopathy, acute, infection-induced, 3 |
IIAE3 |
608,033 |
SAMHD1 |
Aicardi-Goutieres syndrome 5 |
AGS5 |
612,952 |
SLC25A1 |
Combined D-2- and L-2-hydroxyglutaric aciduria |
D2L2AD |
615,182 |
SLC25A22 |
Epileptic encephalopathy, early infantile, 3 |
EIEE3 |
609,304 |
SPTLC1 |
Neuropathy, hereditary sensory and autonomic, type IA |
HSN1A |
162,400 |
TECR |
Mental retardation, autosomal recessive 14 |
MRT14 |
614,020 |
THOC2 |
Mental retardation, X-linked 12 |
MRX12 |
300,957 |
TUBB3 |
Cortical dysplasia, complex, with other brain malformations 1 |
CDCBM1 |
614,039 |
TUBB4A |
Leukodystrophy, hypomyelinating, 6 |
HLD |
612,438 |
USP9X |
Mental retardation, X-linked 99 |
MRX99 |
300,919 |
USP9X |
Mental retardation, X-linked 99, syndromic, female-restricted |
MRXS99F |
300,968 |